Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?
Drug patent watch trametinib?
Drugpatentwatch market analysis industry today?
Is guselkumab off patent in u s?
Albendazole side effects in humans?

Albendazole & ivermectin tablets uses?

See the DrugPatentWatch profile for Albendazole

Albendazole and ivermectin are both anti‑parasitic medications, but they target different kinds of parasites and are used for different clinical conditions. Below is a quick reference to their most common uses:

Drug Class Typical Indications Key Points
Albendazole Broad‑spectrum benzimidazole anthelmintic • Intestinal nematodes: roundworm (Ascaris lumbricoides), hookworm (Ancylostoma duodenale / Necator americanus), whipworm (Trichuris trichiura)
• Strongyloides stercoralis (strongyloidiasis)
• Echinococcus (hydatid disease, when combined with other agents)
• Taenia species (tapeworm)
• Filariasis (in combination with doxycycline for lymphatic filariasis)		 • Usually taken as a single dose (400 mg) or multiple days (e.g., 400 mg twice daily for 5–7 days).
• Absorption is enhanced with a fatty meal.
• Monitor liver enzymes; rare hepatotoxicity can occur.
Ivermectin Macrocyclic lactone anthelmintic • Onchocerca volvulus (river blindness)
• Strongyloides stercoralis (strongyloidiasis)
• Loa loa (if available, in controlled settings)
• Sarcoptes scabiei (scabies)
• Demodex species (rarely)
• Cutaneous larva migrans (in some regions)		 • Commonly given as a single dose (0.2 mg/kg) for most infections.
• For onchocerciasis, repeat dosing every 6–12 months.
• Side‑effects usually mild (headache, dizziness); rare neuro‑toxicity in patients with very high parasite loads.

How the Drugs Work

  • Albendazole: Inhibits microtubule polymerization by binding to β‑tubulin, disrupting glucose uptake and depleting energy stores in parasites.
  • Ivermectin: Opens glutamate‑gated chloride channels in parasite nerve and muscle cells, causing hyperpolarization, paralysis, and death.

Choosing the Right Drug

Parasite Preferred Drug Why
Ascaris, hookworm, whipworm Albendazole Broad spectrum for soil‑transmitted helminths.
Strongyloides Ivermectin (often preferred) More effective in hyper‑infection cases; albendazole also works.
Onchocerca Ivermectin Gold standard for river blindness.
Loa loa Ivermectin (with caution) Effective but can cause serious neuro‑toxicity in high loads; careful screening required.
Scabies Ivermectin Oral therapy works well, especially in crusted scabies or when topical treatments fail.
Hydatid cysts Albendazole (with surgery or PAIR) Suppressive therapy before/after surgery.

Safety & Precautions

  • Pregnancy: Both drugs are category C; use only if benefits outweigh risks.
  • Liver disease: Monitor liver function tests, especially with albendazole.
  • Drug interactions:
    • Albendazole is a CYP3A4 substrate; concurrent strong inhibitors or inducers can affect its plasma levels.
    • Ivermectin is metabolized by CYP3A4/5; concomitant inhibitors (e.g., ketoconazole) or inducers (e.g., rifampin) can alter efficacy.
  • Allergies: Rare hypersensitivity reactions reported with both.
  • Adverse effects:
    • Albendazole: gastrointestinal upset, headache, transient liver enzyme elevation.
    • Ivermectin: dizziness, pruritus, rash; rarely neuro‑toxicity (especially in Loa loa hyper‑infection).

Practical Tips

  1. Take with food – improves albendazole absorption; ivermectin can be taken with or without food.
  2. Complete the full course – even if symptoms resolve early to prevent relapse or resistance.
  3. Follow-up – For strongyloidiasis and onchocerciasis, repeat serologic or antigen tests to confirm cure.

Bottom Line

  • Albendazole = go-to drug for most intestinal worms and hydatid disease.
  • Ivermectin = preferred for onchocerciasis, strongyloides, scabies, and other cutaneous parasitic infections.

Always consult a healthcare provider before starting either medication to ensure the right choice, dose, and monitoring plan for your specific situation.



Other Questions About Albendazole :

Albendazole tablet price? Albendazole? Albendazole tablet 400 mg dose for adults? Albendazole kids? Albendazole tablets ip 400mg? Albendazole tablet price 1 tablet? Albendazole api price?

AI-Drug Label Prescribing Information Alignment Report

22
22%
Grade F

Unsafe

Not Aligned

Patient Risk: High

Summary

Most claims cannot be verified against the provided FDA label excerpts (many are marked absent from the excerpts). Mechanism and many indications for both albendazole and ivermectin are unsupported by the supplied text, and no critical safety/administration labeling (contraindications, boxed warnings, dosing) is available to confirm related claims.

Category Scores

Indication
15
Poor
Dosage
0
Poor
DrugInteractions
25
Poor

Accurate Statements

Albendazole is a synthetic, anthelminthic drug of the class benzimidazole.
Label excerpt 12.1 (provided text: 'Albendazole is a synthetic, anthelminthic drug of the class benzimidazole').
Patients being treated for neurocysticercosis should receive appropriate steroid and anticonvulsant therapy as required (and corticosteroids should be considered during the first week of treatment).
Label excerpt 2.2 (provided text referencing neurocysticercosis and corticosteroids/anticonvulsants).

Unsupported Statements

Albendazole is a broad-spectrum benzimidazole anthelmintic.
Provided 12.1 excerpt does not state 'broad-spectrum'.
Albendazole is used to treat pinworm infections (Enterobius vermicularis).
No pinworm indication content provided in available label excerpts (1 INDICATIONS AND USAGE content not shown).
Albendazole is used to treat roundworm infections (Ascaris lumbricoides).
No Ascaris indication content provided in available label excerpts.
Albendazole is used to treat hookworm infections (Ancylostoma duodenale and Necator americanus).
No hookworm indication content provided in available label excerpts.
Albendazole is used to treat whipworm infections (Trichuris trichiura).
No whipworm indication content provided in available label excerpts.
Albendazole is used to treat taeniasis (tapeworm infections).
No taeniasis indication content provided in available label excerpts.
Albendazole is used to treat larva migrans.
No larva migrans indication content provided in available label excerpts.
Albendazole is used to treat cysticercosis (caused by pork tapeworm larvae).
Provided excerpt discusses neurocysticercosis concomitant therapy but does not explicitly provide the drug indication 'cysticercosis' or specify 'pork tapeworm larvae' in the provided text.
Albendazole is used to treat echinococcosis (hydatid disease caused by dog tapeworm larvae).
No echinococcosis/hydatid indication content provided in available label excerpts.
Albendazole works by binding to beta-tubulin in parasitic worms, inhibiting tubulin polymerization into microtubules.
Provided 12.1 excerpt does not include beta-tubulin/microtubule mechanism.
Albendazole disrupts glucose uptake and energy metabolism in parasitic worms, leading to parasite death.
Provided 12.1 excerpt does not include glucose uptake/energy metabolism mechanism.
Ivermectin is an avermectin-class antiparasitic agent.
No ivermectin-specific information is present in the provided label excerpts.
Ivermectin is effective against a range of internal and external parasites.
No ivermectin indication/content is provided in available label excerpts.
Ivermectin is used to treat onchocerciasis (river blindness) caused by Onchocerca volvulus.
No ivermectin onchocerciasis indication content provided in available label excerpts.
Ivermectin is used to treat strongyloidiasis (intestinal threadworm infection).
No ivermectin strongyloidiasis indication content provided in available label excerpts.
Ivermectin is used to treat scabies and lice infestations.
No ivermectin scabies/lice indication content provided in available label excerpts.
Ivermectin binds to glutamate-gated chloride ion channels in invertebrate nerve and muscle cells.
No ivermectin mechanism text provided in the provided label excerpts.
Ivermectin increases chloride ion membrane permeability, causing hyperpolarization, paralysis, and death of the parasite.
No ivermectin mechanism text provided in the provided label excerpts.
There is no established medical indication for combined use of albendazole and ivermectin in tablet form.
Provided excerpts do not address combined albendazole/ivermectin use or tablet-form indication statements.
Using unapproved combinations of albendazole and ivermectin can lead to lack of efficacy.
Provided excerpts do not discuss efficacy outcomes for combined albendazole/ivermectin use.
Using unapproved combinations of albendazole and ivermectin can increase the risk of side effects.
Provided excerpts do not discuss side-effect risk from combined albendazole/ivermectin use.
Potential interactions could occur when albendazole and ivermectin are combined.
No specific drug interaction content for albendazole plus ivermectin is included in the provided excerpts.

Contradictions

Important Omissions

FDA label contraindications, boxed warning content, dosing/administration, and key warnings/precautions are not provided in the excerpt set, preventing verification of any safety/administration assertions related to albendazole (and especially ivermectin) or combined therapy.
Importance: High
Complete 1 INDICATIONS AND USAGE section text is not provided; therefore, disease-specific indications for albendazole/ivermectin cannot be verified against the label.
Importance: High

Safety Assessment

Potential Patient Risk: High
Many core efficacy/indication and mechanism statements are unsupported by the provided FDA label excerpts, and critical safety labeling content is not available for verification. This creates high risk of misinformation relative to the supplied label.

Regulatory Assessment

On Label No
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk High

Recommendation

Not Aligned

Primary Issue
Most claims (especially ivermectin-related and most albendazole indications and mechanisms) are not supported by the provided FDA label excerpts; critical safety/dosing/contraindication sections are not available for assessment.

Suggested Improvement
Restrict claims to what is explicitly present in the supplied label excerpts (e.g., albendazole being a benzimidazole class synthetic anthelminthic and the neurocysticercosis concomitant steroid/anticonvulsant statement). Do not include disease-specific indications or mechanisms unless the relevant label text is provided.

Drug Brand Mention Assessment

Branding Score
18
Visibility
20
Mentioned
Ranking
#1
Sentiment
15
Recommendation Status
discouraged
Brand Perception
Best Known For

broad-spectrum benzimidazole anthelmintic

Core Claims
  • Albendazole is a broad-spectrum benzimidazole anthelmintic
  • It is primarily used to treat infections caused by parasitic worms
  • It works by binding to beta-tubulin and disrupting microtubule formation
Differentiators
  • Targets beta-tubulin in parasitic worms
  • Used for infections from parasitic worms (e.g., pinworm, roundworm, hookworm)
Pricing Perception: Not Mentioned
Competitors Mentioned
Company Visibility Sentiment Rank Recommended
Ivermectin 20%
15 #2 No